Company intelligence / Profile preview

Clark Pharmaceuticals

Webster, Texas, United Stateslncpharma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Neupanex® used clinically for neurologic conditions; claims improvements in dementia & paralysis but no published clinical trial data or regulatory approval cited.

Therapeutic areas: Neurology
Modalities: Neuroregenerative compounds
Industry: Biotech

Beyond the preview

Go deeper on Clark Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clark Pharmaceuticals.

Explore the full profile